| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.10B | -2.8% |
| R&D Expense | $163.5M | +13.1% |
| SG&A Expense | $643.1M | -8.9% |
| Operating Income | $543.4M | -6.0% |
| Interest Expense | $94.7M | +40.3% |
| Pre-tax Income | $483.5M | -8.3% |
| Income Tax | $106.6M | -15.5% |
| Net Income | $376.9M | -6.1% |
| EPS (Basic) | $2.43 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $340.9M | +66.7% |
| Accounts Receivable | $497.5M | -3.4% |
| Inventory | $296.6M | -14.3% |
| Current Assets | $1.33B | -3.8% |
| Total Assets | $4.29B | -1.1% |
| Current Liabilities | $955.3M | +2.7% |
| Long-term Debt | $2.19B | -15.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $455.0M | +41.7% |
| Capital Expenditures | $60.1M | +0.2% |
| Investing Cash Flow | $69.3M | +121.0% |
| Financing Cash Flow | -$387.8M | -11.5% |
| Free Cash Flow | $394.9M | +51.2% |
| -2.8% |
| EPS (Diluted) | $2.42 | -2.8% |
| Total Liabilities |
| $3.40B |
| -9.7% |
| Stockholders' Equity | $890.4M | +54.4% |